Lung cancer: clinical presentation and specialist referral time Source: Eur Respir J 2004; 24: 898-904 Year: 2004
The evidence on CT: lung cancer screening Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006
Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials Source: Breathe, 16 (1) 200013; 10.1183/20734735.0013-2020 Year: 2020
Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer Year: 2007
Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
The European multicenter trial of diagnosis of early lung cancer by autofluorescence bronchoscopy Source: Eur Respir J 2003; 22: Suppl. 45, 206s Year: 2003
Chest CT scans obtained in multicentre clinical routine assessments are sufficient to develop a prediction function for emphysema from lung function Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015
Videothoracoscopic lung biopsy (VATS-LB) in the diagnosis of diffuse interstitial lung disease (DILD) and evaluation of an outpatient surgical approach. A prospective multicentric study Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
Early detection of lung cancer – the NELSON trial results into real-life practice Source: ERS webinars 2019 - Early detection of lung cancer – the NELSON trial results into real-life practice Year: 2019
Slow-growing lung cancer as an emerging entity: from screening to clinical management Source: Eur Respir J 2013; 42: 1706-1722 Year: 2013
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010
Interstitial lung diseases in a lung cancer screening trial Source: Eur Respir J 2011; 38: 392-400 Year: 2011
Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007
Epidemiology, clinical, imaging and histology aspects of lung cancer in IPF Source: Research Seminar 2015 Year: 2015
The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005
Emphysema, COPD and lung cancer screening. Update of an ongoing study Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer Source: Eur Respir J 2006; 28: 915-919 Year: 2006
No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team Source: Eur Respir J 2009; 33: 941-942 Year: 2009
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012